BCL2 and breast carcinoma: Nanoparticles were formed by ternary complexing of DP, a targeted ligand-grafted lysine dendrimer peptide, and pDNA expressing shRNA for the bcl-2 gene, which targets the membrane ER (mER) in breast cancer cells.